Announcements Trials
Browse Landscape

Phase

Phase NA 20Phase 4 3Phase 2 2Phase 3 1Phase 1 1

Status

Withdrawn 1Recruiting 1Completed 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Conditions

Breast Neoplasms 208Neoplasms 130Polycystic Ovary Syndrome 107Carcinoma, Hepatocellular 82Colorectal Neoplasms 77Prostatic Neoplasms 70Stomach Neoplasms 55Lung Neoplasms 51Precursor Cell Lymphoblastic Leukemia-Lymphoma 49Carcinoma, Non-Small-Cell Lung 43Pain, Postoperative 42Pancreatic Neoplasms 41Head and Neck Neoplasms 38Pain 37Liver Neoplasms 36Leukemia, Myeloid, Acute 32Leiomyoma 32Keratosis, Actinic 31Colonic Neoplasms 31Recurrence 30Neoplasm Metastasis 29Multiple Myeloma 28Infertility 28Brain Neoplasms 28Uterine Cervical Neoplasms 26Urinary Bladder Neoplasms 24Ovarian Neoplasms 24Lymphoma 24Esophageal Neoplasms 23Obesity 22

Interventions

Indocyanine Green 1Dry Needling 1Bupivacaine 1Acetylcysteine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 4 × OTHER × Neuroma × Clear all
NCT06164392 2025-01-01

Evaluation of Neuroma Perfusion with Indocyanine Green Fluorescence Angiography

Northwestern University

Phase 4 Withdrawn

Neuroma

NCT04460521 2024-08-23

ACTS

Nova Scotia Health Authority

Phase 4 Recruiting
240 enrolled

Tomaculous neuropathy, Carpal Tunnel Syndrome, Disease, Hand Injuries, Neuroma, Median Neuropathy

NCT01632709 2015-07-21

PPAP

Shirley Ryan AbilityLab

Phase 4 Completed
16 enrolled 12 charts

Neuroma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡